Aemetis Q1: The Thesis Keeps Printing, but a Going-Concern Flag Resets the Risk/Reward

Results vs. Consensus

*AMTX consensus remains thinly covered; the revenue line is best read against the +27% year-over-year growth rather than a precise Street point. The bottom-line $(0.33) loss missed the ~$(0.27) Street estimate by roughly $0.06, and the stock dipped on the print.

Quality of the Print

• Revenue: Genuinely broad-based for the first time, with all three segments up year over year: ethanol grinding into a better margin, dairy RNG volume up 55% to 110,000 MMBtu, and India biodiesel rebounding to $10.5M as OMC shipments resumed. The quality also improved: $4.0M of high-margin 45Z credit income is now recurring rather than catch-up.
• Margins: A second consecutive quarter of positive gross profit ($2.8M) confirms Q4 was not a one-off, even through winter seasonality (management's stated reason adjusted EBITDA was still slightly negative). The ~$8M YoY gross swing and the ~$9.4M adjusted-EBITDA improvement are the cleanest evidence the operating model has turned.
• EPS: The $(0.33) loss, wider than the Q4 $(0.08), reflects winter seasonality and the still-dominant ~$13M+ interest line, and it missed the Street. The below-the-line financing cost remains the gap between an operationally improving business and a still-large net loss, which is exactly what the now-urgent refinancing must fix.

Segment Performance

Dairy Renewable Natural Gas (Biogas)

Dairy RNG sold 110,000 MMBtu, up 55% year over year, and contributed $1.4M of the quarter's $4.0M of 45Z. The seven approved CARB pathways now sit at an average negative-380 carbon intensity (versus a negative-150 default), with six more pathways nearing approval. The build-out continues: H2S cleanup and biogas-compression equipment is contracted for 15 additional digesters (four units already delivered), on track to double the operating network into 2027.

"In dairy RNG, we sold 110 thousand MMBtus in Q1, a 55% increase over the same quarter last year... we are on track to double our operating dairy network with construction into 2027." — Eric McAfee, Chairman & CEO

Assessment: The segment is executing on plan: volume scaling, pathways stacking, and now contributing recurring 45Z. It is the strongest part of the story operationally. The constraint is no longer the segment's trajectory but whether the parent's balance sheet allows the digester build-out to proceed uninterrupted.

California Ethanol

Keyes contributed the larger $2.6M slice of Q1 45Z and remains the operating spine. The ~$40M MVR project has moved from planning to execution: major equipment is on-site (turbofans from Germany, the main evaporator in transit from India), demolition has begun, and completion is targeted for later in 2026, adding an estimated $32M of annual cash flow from natural-gas savings plus 45Z/LCFS uplift on a lower carbon intensity.

"Major equipment for the $40 million mechanical vapor compression project at our Keyes ethanol plant has arrived on-site and construction has begun... we expect MVR commissioning later this year to add approximately $32 million in annual cash flow from operations." — Eric McAfee, Chairman & CEO

Assessment: The MVR is the most concrete near-term self-help in the model and it is progressing on schedule with no qualification lag and no dilution. It is the clearest reason to expect the operating turn to deepen through H2 2026, independent of the DOE timeline.

India Biofuels

India biodiesel rebounded to $10.5M, though the 80-million-gallon plant has been running near only 10% capacity. Management framed a coming structural shift: India had frozen pump diesel prices through May elections despite surging crude, leaving the OMCs losing money on every gallon, a situation "about to change" with a sharp diesel price increase that should restore biodiesel demand and a return to the cost-plus contract model (which previously generated $112M of revenue and ~$14M of cash flow). The subsidiary, Universal Biofuels Private Limited, has retained legal, accounting, and IPO advisers.

"We have an 80 million gallon plant that has been operating recently at 10% capacity... the price of diesel in India [should] dramatically increase... we are setting up our IPO to be directly correlated with when those policies are adopted." — Eric McAfee, Chairman & CEO

Assessment: The India story is high-potential but remains the most policy-dependent and least controllable piece, now explicitly tied to an Indian government pricing decision and post-election policy adoption. A return to cost-plus and a successful IPO would be a major value-surfacing event; a continued 10%-utilization stall would push the IPO timeline. It is optionality, not a near-term certainty.

Key Topics & Management Commentary

Overall Management Tone: Confident on operations and notably more expansive on the long-dated prizes (the 80-million-gallon SAF/RD plant, the India IPO, LCFS at $150 in 2027), but conspicuously lighter on the one subject that now matters most. The going-concern qualification and the $342.6M near-term maturity wall were addressed only obliquely, reframed as "refinancing opportunities" expanding into municipal-bond and private-credit markets rather than as the solvency contingency the 10-Q describes. The recurring "should/before June" hedge on the DOE spreadsheet persisted for a fourth straight quarter.

The Refinancing Is Now a Solvency Requirement, Not a Catalyst

Asked for color on the financing options, management pointed to municipal-bond financing of the Third Eye bridge, plus commercial and private-credit discussions, framing improved margins as expanding the refinancing menu. The senior debt has been held for 18 years by a roughly $3B Toronto fund; only ~$50M is other U.S. debt.

"We are actively in the market right now working on a municipal bond type refinancing of our existing bridge financing we got from Third Eye Capital... I think we will be seeing much larger financings and moving much quicker than what the USDA program currently looks like." — Eric McAfee, Chairman & CEO

Assessment: The 18-year senior-lender relationship and the demonstrated ability to monetize credits make a refinancing plausible, and the improving margins genuinely help. But the 10-Q's going-concern language and the "due on demand" character of $342.6M of debt mean this is no longer optional or merely value-accretive. Until a refinancing actually closes, the equity carries a solvency tail that a $3.12 price, up 133% YTD, does not adequately reflect.

The DOE GREET Spreadsheet: Still Pending After More Than a Year

The full 45Z value remains gated on the DOE posting the updated GREET calculator. Treasury finalized its guidance in February 2026; the spreadsheet that would let the company calculate full 45Z (and let lenders size the fourth revenue leg) has still not posted. Management expects it "certainly before June."

"Federal law is passed. Treasury adopted their guidance in February 2026 for 45z, but the actual calculator on the Department of Energy website... needs to be posted with the updated rules in the spreadsheet in order to finalize that fourth leg of the stool. I want to put that note on the table that that is having an impact." — Eric McAfee, Chairman & CEO

Assessment: This is the crux of the timing risk and the reason the refinancing and the SAF financing are both stalled: lenders want the 45Z number, and only the DOE can provide the calculator. The company recognized $4.0M of 45Z under existing rules, which proves the mechanism works, but the full step-up that the bull case capitalizes is still waiting on a federal posting that has slipped repeatedly.

The SAF / Renewable Diesel Plant Re-Enters the Frame

With renewable-diesel margins recovering (SAF quoted near $9.80/gallon, ~$1.60/gallon industry operating margin), management revived the 80-million-gallon SAF (90-million-gallon RD) Riverbank project, fully permitted with 10 airline agreements signed, framing ~$800M of potential revenue. Financing is the only remaining gate, itself partly dependent on the 45Z number.

"That 80 million gallons, of course, if we are selling at $9.80 a gallon, is almost $800 million additional revenue... we are definitely making progress on the financing; that is actually the only remaining part of this." — Eric McAfee, Chairman & CEO

Assessment: The SAF plant is a genuinely large long-dated option, and the improved margin backdrop makes it more financeable than in 2024. But it is a multi-hundred-million-dollar project for a company with $4.8M of cash and a going-concern flag; it belongs firmly in the optionality bucket, contingent on the balance sheet being fixed first.

LCFS Prices: Conviction High, Timing Pushed

LCFS prices have stayed muted despite the program flipping to deficit generation. Management attributed the lag to traders mis-pricing post-Iranian-war driving demand and to weak renewable-diesel credit generation, while holding firm that the trend is up, with $150 plausible in 2027 against the $268 cap.

"I would not be surprised at all to see $150 in 2027 as traders see the cap as $268, and they want to get their book filled up as soon as possible." — Eric McAfee, Chairman & CEO

Assessment: The LCFS thesis is intact but the timeline slipped: the $100-this-year framing from the Q4 call has effectively become a 2027 $150 story. The price tailwind the model leans on is real but is arriving slower than management projected last quarter, which matters for the near-term cash bridge.

Section 48 ITC Cadence on the Doubling Digester Network

On the 15 new digesters, management explained ITCs are earned on each unit's in-service date (not at full-program completion), with ~$95M of ITCs sold to date and an expectation of at least one sale per quarter, likely a Q3 contribution, to a single recurring buyer.

"We get the tax credits upon the completion, the in-service date, for each single digester... we do expect to have a single party this year acquire each one of the investment tax credit projects that we generate. We will be seeking to do at least once a quarter." — Eric McAfee, Chairman & CEO

Assessment: The per-digester ITC mechanism provides a recurring, near-term cash source tied to construction milestones, which partially self-funds the build-out and is one of the more reliable cash levers in the model. It helps the liquidity bridge but does not, by itself, retire the $342.6M maturity wall.

Guidance & Outlook

No formal numeric guidance. The 2026 priorities are explicit: scale production, monetize the stacked credit value, complete the India IPO, and refinance existing debt into long-term financing. The tracked catalysts are the DOE 45Z GREET spreadsheet, MVR commissioning, rising LCFS prices, and India IPO progress.

Implied near-term ramp: The operating trajectory points up (MVR, recurring 45Z, dairy scaling), but the two items that most move the equity, full 45Z recognition and the refinancing, both remain gated on a DOE posting that has slipped four quarters running.

Street at: After a 133% YTD move, the stock at $3.12 has re-rated to roughly fair on the realized catalysts; further upside increasingly requires the still-pending big catalysts (full 45Z, refinancing close, India IPO) to land.

Guidance style: Operationally confident, but the going-concern and maturity-wall facts in the 10-Q were softened in the call's framing relative to their weight in the filing.

Analyst Q&A Highlights

Debt Refinancing Options and the Senior Lender

An analyst asked for more color on the financing options for addressing the debt broadly, including Keyes and the dairy RNG projects. Management laid out a municipal-bond and private-credit path and noted the 18-year senior-lender relationship.

Q: "Can you provide more color around the financing commentary from the release? Just looking to better understand the options available to you on addressing the debt broadly, and the status of the refunding for the dairy RNG projects?"
— Nate Pendleton, Texas Capital

A: "We have been funded and supported for the last 18 years by roughly a $3 billion fund out of Toronto that holds our senior debt, except for the $50 million of U.S. debt... We are actively in the market right now working on a municipal bond type refinancing of our existing bridge financing." — Eric McAfee, Chairman & CEO

Assessment: The relationship depth and the menu of options are reassuring, but the answer described expanding "opportunities" rather than a committed transaction. Against a going-concern qualification, the absence of a closed or term-sheeted refinancing is the gap between the operating story and an investable balance sheet.

The SAF/RD Plant Economics and the Missing Fourth Revenue Leg

The opening question revisited the long-dormant SAF/RD project in light of the robust 2026–2027 RVO. Management sized the opportunity but flagged that the missing 45Z calculation is itself holding up the project financing.

Q: "Could you talk about the possibility of the RD and SAF plant... in light of the very robust 2026 and 2027 RVO? Refresh us on how much it would cost and what capacity it would provide."
— Matthew Blair, Tudor, Pickering, Holt & Co.

A: "The capacity is 80 million gallons a year of SAF, or... 90 million gallons [RD]... there are actually four different sources of revenue for that plant, and 45z... is still an unknown... Most lenders especially are interested in knowing what the 45z revenue is for this project." — Eric McAfee, Chairman & CEO

Assessment: The exchange usefully connected the dots: the same DOE delay that gates the parent refinancing also gates the SAF project financing. Improved RD/SAF margins make the project more attractive, but the financing bottleneck is the same single regulatory posting, which concentrates the company's catalyst risk in one external event.

India Volumes, Pricing, and the Coming Diesel Shock

Questioning probed India Q2 expectations and whether pricing would carry a premium to recent levels. Management tied the outlook to an imminent Indian diesel price increase and a return to cost-plus contracting.

Q: "The India biodiesel operations — nice to see them restarted. It looks like profitability is essentially breakeven... Could you talk about your expectations for the second quarter? Do you think volumes will be in a similar range, and do you expect margin improvement?"
— Matthew Blair, Tudor, Pickering, Holt & Co.

A: "We are seeing dramatic increases and, frankly, signing larger contracts and going back to the cost-plus contract model... I think you will see that kind of certainty come into play [over] the next few months." — Eric McAfee, Chairman & CEO

Assessment: The cost-plus restoration (previously $112M revenue / ~$14M cash flow) would be a meaningful India improvement and a tailwind into the IPO. But it depends on an Indian government pricing action that has been deferred for political reasons, the same policy dependence that has whipsawed India volumes for two years.

MVR Certification and the Path to the $32M Run-Rate

An analyst asked whether the MVR requires additional certification before generating its incentive-based cash flows. Management confirmed no further certification is needed and that the major equipment is largely on-site.

Q: "On the MVR... are there any additional certifications or verifications needed before you can start generating that $32 million annualized return? I know some will be immediate from lower natural gas consumption, but for the other incentive-based cash flows, do you need to do anything?"
— Sameer Joshi, H.C. Wainwright

A: "No, there are no additional certifications necessary. We received an authority to construct from the air district... we have received most of the major equipment stateside now... All of the big-ticket items... are either on-site or will be on-site within the next week or so." — Andy Foster, President, Aemetis Advanced Fuels

Assessment: The most de-risked answer of the call. No certification lag, equipment on-site, construction underway: the MVR's ~$32M/year contribution is the one major 2026 lever that is neither DOE-gated nor financing-gated, and it should begin to show in H2.

LCFS Deficit Generation and Muted Prices

An analyst noted that LCFS prices have stayed muted even as the market flipped to deficit and asked for the forward view. Management argued for a rapid summer/fall increase and explained the trailing-deficit reporting lag and weak RD credit generation.

Q: "While the market has flipped to deficit generation recently, prices have broadly remained quite muted. Can you talk about your expectations for that market going forward?"
— Nate Pendleton, Texas Capital

A: "I think we are going to see a rapid price increase during the summer and early fall... I would not be surprised at all to see $150 in 2027." — Eric McAfee, Chairman & CEO

Assessment: The conviction is unchanged but the timeline has clearly stretched, from "$100 this year" at Q4 to "$150 in 2027" here. For a company that needs near-term cash, an LCFS tailwind that is increasingly a 2027 story is less helpful to the immediate liquidity bridge than the Q4 framing implied.

Pathway Approvals and the Look-Back Mechanism

An analyst asked whether the six pending negative-380 pathway approvals are a first-half or second-half event. Management described CARB's roughly two-quarter look-back, implying a potential one-quarter catch-up.

Q: "You got seven LCFS pathways approved for the negative 380. Six are being worked on. Should we expect those to occur in the first half, or is it a second-half event?"
— Sameer Joshi, H.C. Wainwright

A: "An approval by December is actually effective July 1. Strange situation, but... we do expect by the end of the year to see appropriate progress here with a look-back that looks like a six-month look-back." — Eric McAfee, Chairman & CEO

Assessment: The look-back means the additional pathway value is largely a late-2026 catch-up rather than a near-term contributor, consistent with the broader theme of this quarter: the operating ramp is on track, but much of the incremental credit value is back-half-or-later weighted while the balance sheet pressure is immediate.

What They're NOT Saying

1. A plan for the $342.6M due on demand: The call reframed the maturity wall as expanding "refinancing opportunities" without a committed transaction, term sheet, or timeline against debt the 10-Q describes as callable on demand.
2. The going-concern qualification itself: The substantial-doubt language in the filing was not directly addressed in the prepared remarks; management led with revenue growth and gross profit instead.
3. A firm DOE date, for the fourth straight quarter: "Before June" repeats a framing that has slipped repeatedly; no commitment was offered on what happens to the refinancing if it slips again.
4. Dilution as a bridge: With $4.8M of cash, an existing ATM, and a going-concern flag, equity issuance is a live risk that the call did not address even as the stock trades up 133% YTD.
5. India utilization economics at 10%: The plant is running near 10% of capacity, but the call emphasized the coming policy shift rather than the current cash drag of an underutilized facility.

Market Reaction

• Pre-print setup: AMTX closed at $3.24 the day before the release, up a remarkable 133.1% year-to-date and 149.2% over the trailing twelve months, near the top of its $1.25–$3.66 52-week range. The re-rating our Q4 upgrade anticipated had largely played out into the print.
• Reaction-day session: The stock opened down 4.9% at $3.08, fell as low as $2.69 (-17.0%), then recovered to close at $3.12, off 3.7% ($0.12), on roughly 1.6x average volume. The S&P was down 0.4% on the session.

After a triple, a 3.7% dip on an operationally fine print is the market saying the easy money is made. The intraday plunge to -17% before the recovery is the more telling tell: when the going-concern language and the $342.6M maturity wall hit the tape, the stock briefly repriced the solvency risk, then steadied as buyers focused on the recurring 45Z and the catalyst pipeline. The net move says expectations have caught up with the price, and that from here the stock needs the big pending catalysts to deliver rather than simply not disappoint.

Street Perspective

Debate: Does the Going-Concern Flag Change the Story or Just Formalize a Known Risk?

Bull view: The going-concern language is a technical accounting consequence of "due on demand" senior debt held by an 18-year partner who has supported the company throughout; with margins now positive and 45Z recurring, a municipal-bond or private-credit refinancing is a matter of time, not survival.

Bear view: An explicit substantial-doubt qualification with $342.6M callable against $4.8M of cash is exactly the setup where a single change in lender posture, or another DOE slip, forces a deeply dilutive raise or a distressed restructuring that impairs the equity regardless of operating progress.

Our take: Probably the former, but the tail is real and is no longer free at $3.12. After a 133% run, the market is paying for the upside scenario while a genuine solvency contingency sits unpriced. That asymmetry is the basis for moving to Hold.

Debate: Is the Stock Still Cheap After Tripling?

Bull view: Even at $3.12, the company is pre-full-45Z, pre-MVR-contribution, pre-India-IPO, and pre-SAF; the realized catalysts justify the move and the pending ones (full 45Z, $800M SAF revenue, India IPO) dwarf the current ~$160M market cap.

Bear view: The deep mispricing has been arbitraged away; what remains is a fairly-valued option on catalysts that keep slipping (DOE four quarters running, LCFS to 2027), attached to a balance sheet that could force dilution before the options pay off.

Our take: The remaining upside is large but no longer asymmetric to the downside at this price. We would rather re-engage after the refinancing closes (removing the solvency tail) or the DOE posts (unlocking full 45Z), even at a higher price, than own the gap in between.

Debate: How to Weight the India IPO and SAF Optionality

Bull view: A diversified India biofuels IPO and a fully-permitted 80-million-gallon SAF plant into a recovering RD/SAF margin are each potentially company-making, and both are advancing.

Bear view: Both are gated on the same two unresolved items, the 45Z calculation and financing, and India is additionally gated on an Indian government pricing decision; "advancing" is not "closed" for either.

Our take: Real, large, and correctly valued as options rather than base cases. They keep us at Hold rather than Underperform despite the going-concern flag, because a single positive resolution (DOE posting, refinancing close, or India IPO) could re-skew the risk/reward back to the upside quickly.

Model Implications

Valuation impact: The realized catalysts justify the stock's re-rating from ~$1.92 to ~$3.12, but at the current price the risk/reward has flattened: the large remaining upside (full 45Z, India IPO, SAF) is balanced by a going-concern solvency tail and catalysts that keep slipping. We frame fair value as roughly the current area, with a wide two-sided band, and prefer to re-underwrite after either the refinancing closes or the DOE spreadsheet posts.

Thesis Scorecard Post-Earnings

Overall: Thesis intact and operationally confirmed, but the risk/reward inverted with the price. Bull-1 strengthened (recurring 45Z, second gross-profit quarter), while Bear-1 escalated back to materializing on the going-concern disclosure and the due-on-demand maturity wall. After a 2.5x re-rating, the two no longer favor the equity.

Action: Downgrade to Hold from Outperform. Harvest the re-rating; re-engage when the refinancing closes (removing the solvency tail) or the DOE posts the GREET spreadsheet (unlocking full 45Z), either of which could re-skew the risk/reward back to the upside.